Weight loss stocks can vary dramatically in risk profile and growth potential. However, the industry outlook is strong, with spending projected to grow from $2 billion in 2022 to $10 billion by 2027.

The diabetes and weight loss drug market is heating up in 2025, with significant growth signs everywhere. According to a recent study from Research and Markets, industry growth is running at an ...